Research led by the Departments of Dermatology, Pathology and Molecular Genetics of the Hospital Universitari Arnau de Vilanova de Lleida (HUAV) and the Oncological Pathology research group of the Universitat de Lleida (UdL) and the Institute for Research in Biomedicine of Lleida (IRBLleida) has identified …
A research team coordinated from the Universitat Autònoma de Barcelona (UAB), with the participation of Judit Ribas, lecturer at the University of Lleida and head of the IRBLleida Pharmacology Unit research group, describes how a substance called gossypol primes glioblastoma cells, an incurable type of …
Lleida, through the Clinical Trials unit of the Biomedical Research Institute of Lleida (IRBLleida), is participating in the Destiny-Breast clinical trials programme to tackle HER2+ breast cancer. Specifically, it has participated in Destiny-Breast 2 and is currently participating in Destiny-Breast 5, which involves patients with …
The use of emerging senolytic drugs, which attack senescent or ageing cells, could improve people who have suffered an ischaemic stroke due to a lack of blood flow to the brain. This is according to research by the University of Lleida (UdL) and the Institute …
The therapeutic advances are in contrast to the devastating effects that COVID-19 has had on the evolution of many patients Fifteen patients from the Cognitive Disorders Unit of the University Hospital of Santa Maria (HUSM) have taken part in the clinical trials that have led …
Research by the UdL and IRBLleida describes how they are necessary for the formation and migration of interneurons Defects in the formation and migration of interneurons or inhibitory neurons in the cerebral cortex, related to disorders such as schizophrenia or autism spectrum syndromes, could be …
The Metabolic Pathophysiology group of the UdL-IRBLleida participates in a project to improve the understanding of Alexander disease, a rare disease that progressively destroys the white matter of the brain. The Fundació “la Caixa” has announced today the 30 projects selected in the CaixaResearch call …
Colorectal cancer (CRC) is the most frequent neoplasm in Western countries, the second most frequent neoplasm after breast cancer in women and the third most frequent neoplasm after prostate and lung cancer in men. Survival at five years, if all stages are taken into account, …
Dr Abel López-Bermejo and Dr. Judit Bassols from IDIBGI participate in a new European project SPIOMET4HEALTH to treat PCOS. The project, funded by the European Commission with €6 million, involves a consortium of 17 research groups from 9 European countries. SPIOMET4HEALTH will test a novel …
According to research that has analysed the 100 most cited articles in the medical literature The territorial clinical director of chronic respiratory diseases at the Arnau de Vilanova University Hospital of Lleida (HUAV), professor at the Faculty of Medicine of the University of Lleida (UdL) …
According to research led in Lleida by the Translational Research in Respiratory Medicine group at IRBLleida, the University of Lleida, the Arnau de Vilanova and Santa Maria de Lleida Hospitals, and CIBERES A microRNA profile, small ribonucleic acid sequences, predicts the severity of COVID-19 in …